Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8778 |
High Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8757 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8706 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8693 |
High Similarity |
NPD7472 |
Approved |
0.8693 |
High Similarity |
NPD7074 |
Phase 3 |
0.8644 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8636 |
High Similarity |
NPD7054 |
Approved |
0.8603 |
High Similarity |
NPD8312 |
Approved |
0.8603 |
High Similarity |
NPD8313 |
Approved |
0.858 |
High Similarity |
NPD3818 |
Discontinued |
0.8547 |
High Similarity |
NPD7808 |
Phase 3 |
0.8492 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8436 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8427 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8378 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8372 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8362 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8362 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8362 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8249 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8208 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8192 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8167 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8161 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8122 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8057 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8057 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8057 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8056 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7978 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7966 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.794 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.794 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7921 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7921 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7914 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7889 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7874 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7869 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7857 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7817 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7809 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7802 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD37 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7784 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7765 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7753 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD1511 |
Approved |
0.774 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7714 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7704 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7677 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7677 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7677 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7657 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7612 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7512 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7471 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7457 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7449 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7449 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7443 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7416 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7413 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7409 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7401 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7401 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7387 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7376 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7326 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7238 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7238 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD919 |
Approved |
0.7184 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7151 |
Intermediate Similarity |
NPD943 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD447 |
Suspended |
0.709 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7079 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7052 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7026 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7018 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7 |
Intermediate Similarity |
NPD5711 |
Approved |
0.6989 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6983 |
Remote Similarity |
NPD7003 |
Approved |
0.6981 |
Remote Similarity |
NPD7930 |
Approved |
0.6971 |
Remote Similarity |
NPD1607 |
Approved |
0.6959 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD5353 |
Approved |
0.6943 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6942 |
Remote Similarity |
NPD5005 |
Approved |
0.6942 |
Remote Similarity |
NPD5006 |
Approved |
0.694 |
Remote Similarity |
NPD920 |
Approved |
0.6938 |
Remote Similarity |
NPD7585 |
Approved |
0.6923 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6907 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD7583 |
Approved |
0.6879 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD5242 |
Approved |
0.6854 |
Remote Similarity |
NPD6100 |
Approved |
0.6854 |
Remote Similarity |
NPD6099 |
Approved |
0.6839 |
Remote Similarity |
NPD3764 |
Approved |
0.6836 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6833 |
Remote Similarity |
NPD2800 |
Approved |
0.6833 |
Remote Similarity |
NPD1243 |
Approved |
0.6829 |
Remote Similarity |
NPD4420 |
Approved |
0.6821 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6816 |
Remote Similarity |
NPD2344 |
Approved |
0.6813 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6798 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6796 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6793 |
Remote Similarity |
NPD6273 |
Approved |
0.6789 |
Remote Similarity |
NPD7907 |
Approved |
0.6772 |
Remote Similarity |
NPD4288 |
Approved |
0.6766 |
Remote Similarity |
NPD6842 |
Approved |
0.6766 |
Remote Similarity |
NPD6841 |
Approved |
0.6766 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6765 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6744
|
Remote Similarity |
NPD1203 |
Approved |